Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Alnylam Pharmaceuticals, Inc.

ALNY Technical Analysis Summary (NASDAQ)

Analyze ALNY on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.

ALNY●NASDAQ
HealthcareBiotechnology
$254.07
$1.29(0.51%)
U.S. Market opens in 6h 23m

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

ALNY Technical Analysis Summary (NASDAQ)

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stock currently shows a neutral trend on the NASDAQ, supported by momentum and balanced buying pressure.

Overall Sentiment:Neutral
Momentum:Neutral to Bullish (RSI: 54.49)
Trend Strength:Weak (ADX: 14.81)
Volatility:Medium (ATR: 9.72)
Support/Resistance:$234.53 – $268.34 (Bollinger Bands)

Technical conditions suggest Alnylam Pharmaceuticals, Inc. on the NASDAQ is awaiting a decisive move. This mix signals that Alnylam Pharmaceuticals, Inc. is trading in a balanced range with no clear breakout yet.

Momentum Indicators

RSI (14): 54.49

Bullish
Above midpoint suggests upward bias.

Stochastic %K: 71.82

Bullish
Buying momentum building without extremes.

Williams %R: -14.39

Bearish
Overbought levels may trigger correction.

Rate of Change (ROC): -1.47

Bearish
Selling pressure outweighs buying.

Takeaway:Alnylam Pharmaceuticals, Inc. shows steady upward momentum, supported by improving signals.

Trend & Volatility

MACD: 1.70

Bullish
Bullish, trend momentum is strengthening.

ADX: 14.81

Weak
Weak trend, market trading sideways.

ATR (14): 9.72

Rising
Rising volatility, market activity increasing.

CCI (14): 104.44

Bearish Risk
Bearish risk, overbought levels suggest caution.

Takeaway:Alnylam Pharmaceuticals, Inc. shows a neutral trend, with weak conviction and limited volatility.

Support & Resistance indicators
Bollinger Bands
Upper Band
$268.34
Middle Band (SMA 20)
$251.44
Lower Band
$234.53
Current Position
Within Bands

Takeaway:Alnylam Pharmaceuticals, Inc. trades around the middle band, reflecting balanced price action.

Keltner Channels
Upper Channel
$268.24
Middle Line (EMA 20)
$248.79
Lower Channel
$229.34
Squeeze Status
Squeeze On

Takeaway:Alnylam Pharmaceuticals, Inc. trades above the trend line, showing healthy momentum within the channel.

Volume & Money Flow Analysis
On-Balance Volume545.36K
Money Flow Index32.80Bearish, selling pressure outweighs inflows.
Relative Vigor Index50.32Neutral to Bullish, buyers hold a slight edge.

Overall Takeaway:ALNY shows mixed signals in money flow analysis.

Technical Trading Signals Summary
Based on the current technical analysis of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), here are the key trading signals and recommendations:

Bullish Signals

RSI above 50 → positive momentum from buyers.

MACD above 0 → bullish trend confirmation.

Price trading above middle Bollinger Band → mid-term support intact.

MFI below 80 → room for more buying without overbought risk.

Bearish Signals

No significant bearish signals detected.

Overall Recommendation:Technical indicators for Alnylam Pharmaceuticals, Inc. are mixed, suggesting a Hold or wait-and-see approach.

(NASDAQ: ALNY) Technical Analysis FAQ